| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f03cac91c556becf5ad793965e53482a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-33306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-6852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G81-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G81-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate |
2015-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b3b247d9bacf210d143befa4179136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c266c3fceb02bcf4d6afaaa4198160ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_566507d2727c543b46c2964ad9f7b349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3473f2bbb34e3c71724780bd49002968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7426360e68c44250314f760606452965 |
| publicationDate |
2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017075760-A1 |
| titleOfInvention |
Bridged polyethylene glycol-aliphatic polyester block copolymer, preparation method for same, intermediate of same, and uses thereof |
| abstract |
The present invention relates to a bridged polyethylene glycol-aliphatic polyester block copolymer, applicable in preparing a delivery carrier for a small molecule chemotherapy medicament or a nucleic acid medicament. A nano-medicament carrier prepared with the bridged block copolymer produces specific degradation under the pH environment in a tumor tissue or tumor cells, thus changing the structure of nanoparticles, enhancing cellular uptake or intracellular medicament release, and increasing the sensitivity of tumor cells with respect to the medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113603877-A |
| priorityDate |
2015-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |